Processa Pharmaceuticals Inc

NASDAQ: PCSA    
Share price (5/3/24): $2.26    
Market cap (5/3/24): $6.459 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.14
from S-1/A 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 13 pages Material contract
12/34/56
EX-10.13
from 10-K 23 pages Material contract
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Material contract
12/34/56
EX-10.2
from 8-K 13 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 40 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 51 pages License Agreement by and Between Processa Pharmaceuticals, Inc. and Ocuphire Pharma, Inc. Dated as of June 16, 2021
12/34/56
EX-10.15
from 10-K 5 pages Addendum No. 1 to License Agreement
12/34/56
EX-10.3
from 8-K 13 pages Common Stock Purchase Warrant Processa Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 8 pages Processa Pharmaceuticals Inc. Employment Agreement October 1, 2020
12/34/56
EX-10.13
from S-1/A 51 pages License Agreement by and Between Processa Pharmaceuticals, Inc. and Elion Oncology, Inc Dated as of August 23, 2020
12/34/56
EX-10.12
from S-1/A 20 pages Share Issuance Agreement
12/34/56
EX-10.11
from S-1/A 75 pages License Agreement by and Between Processa Pharmaceuticals, Inc. and Yuhan Corporation Dated as of August 19, 2020
12/34/56
EX-10.9
from S-1/A 50 pages Material contract
12/34/56
EX-10.8
from S-1/A 33 pages Material contract
12/34/56
EX-10.7
from S-1/A 5 pages Material contract
12/34/56